Skip to Content


In the US, Diazoxide (diazoxide systemic) is a member of the following drug classes: agents for hypertensive emergencies, glucose elevating agents and is used to treat Hypertensive Emergency and Hypoglycemia.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antihypertensive agent

Hyperglycemic agent

Chemical Name

2H-1,2,4-Benzotiadiazine, 7-chloro-3-metyl-, 1,1-dioxide

Foreign Names

  • Diazoxidum (Latin)
  • Diazoxid (German)
  • Diazoxide (French)
  • Diazoxido (Spanish)

Generic Names

  • Diazossido (OS: DCIT)
  • Diazoxide (OS: USAN, DCF, BAN, JAN)
  • NSC 64198 (IS)
  • Sch 6783 (IS: Schering)
  • SRG 95213 (IS)
  • Diazoxid (PH: Ph. Eur. 8)
  • Diazoxide (PH: BP 2016, Ph. Eur. 8, Ph. Int. 4, USP 38)
  • Diazoxidum (PH: Ph. Eur. 8, Ph. Int. 4)

Brand Names


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.